Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences

Published:2015-07-30 Issue:11 Volume:70 Page:3087-3095
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Santos José Ramón,Blanco José Luis,Masiá Mar,Gutiérrez Félix,Pérez-Elías María Jesús,Iribarren José Antonio,Force Lluis,Antela Antonio,Knobel Hernando,Salavert Miguel,López Bernaldo De Quirós Juan Carlos,Pino María,Paredes Roger,Clotet Bonaventura

Funder

Lluita contra la SIDA Foundation (Barcelona, Spain)

‘Red Temática de Investigación en SIDA’

ViiV Healthcare

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/70/11/3087/6991803/dkv205.pdf

Reference39 articles.

1. Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients

2. Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1–Infected Patients: 156-Week Results From STARTMRK

3. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

4. Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

5. High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV;International Journal of Antimicrobial Agents;2022-09

2. Association of low‐level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study;HIV Medicine;2022-05-16

3. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort;Infectious Diseases and Therapy;2022-04-11

4. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping;Journal of Antimicrobial Chemotherapy;2020-09-15

5. Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey;PLOS ONE;2019-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3